• HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP

HEMING GROUP

Specialized and innovative report


2025-01-01

 

 Good news: Jiangxi Heping Pharmaceutical Co., Ltd. was awarded the title of "2024 Jiangxi Specialized and New Small and Medium-sized Enterprise" by the Jiangxi Provincial Department of Industry and Information Technology in August 2024. This honor is a significant milestone in the company's development and a high recognition of our work.

  Since its establishment, the company has adhered to the principles of "innovation, focus, quality, and win-win," and is committed to the modernization and internationalization of traditional Chinese medicine.

  Being named a "specialized and new small and medium-sized enterprise" is a high evaluation of the company's technological innovation, product quality, and market competitiveness. This is the result of the joint efforts of all employees and is our shared honor.

  Looking to the future, we will continue to adhere to the development path of "specialized and new," increase R&D investment, promote product innovation, and enhance the company's core competitiveness. At the same time, we will actively participate in industry exchanges and cooperation to contribute to the development of the traditional Chinese medicine industry in Jiangxi Province and even the whole country.